OneMedNet (NASDAQ:ONMD) Insider Jeffrey Yu Acquires 17,000 Shares

Posted by Casey Walker on Nov 27th, 2025

OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) insider Jeffrey Yu purchased 17,000 shares of the business’s stock in a transaction dated Thursday, August 28th. The stock was purchased at an average price of $0.80 per share, for a total transaction of $13,600.00. Following the completion of the acquisition, the insider owned 6,993,934 shares of the company’s stock, valued at approximately $5,595,147.20. This represents a 0.24% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link.

Jeffrey Yu also recently made the following trade(s):

On Thursday, September 25th, Jeffrey Yu acquired 1,250 shares of OneMedNet stock. The shares were purchased at an average price of $1.03 per share, with a total value of $1,287.50.
On Wednesday, September 24th, Jeffrey Yu bought 17,200 shares of OneMedNet stock. The stock was purchased at an average cost of $1.02 per share, for a total transaction of $17,544.00.
On Tuesday, September 23rd, Jeffrey Yu purchased 5,700 shares of OneMedNet stock. The shares were purchased at an average cost of $0.93 per share, with a total value of $5,301.00.
On Monday, September 22nd, Jeffrey Yu purchased 400 shares of OneMedNet stock. The shares were acquired at an average cost of $0.95 per share, with a total value of $380.00.
On Friday, September 19th, Jeffrey Yu acquired 1,250 shares of OneMedNet stock. The stock was acquired at an average price of $0.89 per share, for a total transaction of $1,112.50.
On Thursday, September 18th, Jeffrey Yu bought 700 shares of OneMedNet stock. The shares were acquired at an average price of $0.91 per share, with a total value of $637.00.
On Friday, September 5th, Jeffrey Yu bought 2,100 shares of OneMedNet stock. The stock was acquired at an average cost of $0.86 per share, with a total value of $1,806.00.
On Thursday, September 4th, Jeffrey Yu acquired 11,810 shares of OneMedNet stock. The shares were acquired at an average price of $0.87 per share, with a total value of $10,274.70.
On Wednesday, September 3rd, Jeffrey Yu bought 11,670 shares of OneMedNet stock. The stock was bought at an average cost of $0.81 per share, for a total transaction of $9,452.70.
On Tuesday, September 2nd, Jeffrey Yu bought 24,319 shares of OneMedNet stock. The shares were bought at an average price of $0.85 per share, for a total transaction of $20,671.15.

OneMedNet Price Performance

ONMD stock traded down $0.04 during mid-day trading on Thursday, reaching $1.42. The company had a trading volume of 298,140 shares, compared to its average volume of 762,577. The company has a market capitalization of $72.43 million, a price-to-earnings ratio of -28.40 and a beta of 1.09. OneMedNet Corporation has a 52 week low of $0.30 and a 52 week high of $4.22. The stock has a 50 day simple moving average of $1.77 and a two-hundred day simple moving average of $0.99.

OneMedNet (NASDAQ:ONMD – Get Free Report) last released its quarterly earnings data on Friday, November 14th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.18 million during the quarter.

Institutional Investors Weigh In On OneMedNet

A number of institutional investors have recently modified their holdings of the business. Exencial Wealth Advisors LLC grew its stake in shares of OneMedNet by 3.1% in the second quarter. Exencial Wealth Advisors LLC now owns 1,491,862 shares of the company’s stock valued at $851,000 after acquiring an additional 45,448 shares in the last quarter. Ashton Thomas Private Wealth LLC bought a new stake in OneMedNet in the 3rd quarter valued at about $25,000. Finally, Correct Capital Wealth Management acquired a new position in shares of OneMedNet during the 3rd quarter worth approximately $4,910,000. Institutional investors own 0.95% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Wall Street Zen raised shares of OneMedNet to a “hold” rating in a research report on Friday, September 26th. Weiss Ratings reiterated a “sell (d-)” rating on shares of OneMedNet in a report on Tuesday, October 14th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

View Our Latest Research Report on ONMD

About OneMedNet

(Get Free Report)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.